v3.23.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Exchangeable Stock
Special Voting Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares, issued (in shares)       123,297      
Beginning balance (in shares) at Jan. 30, 2022   5,203 5,203        
Beginning balance at Jan. 30, 2022 $ 2,740,046   $ 0 $ 616 $ 422,507 $ 2,512,840 $ (195,917)
Beginning balance (in shares) at Jan. 30, 2022       123,297      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 734,989         734,989  
Other comprehensive income (loss), net of tax (95,890)           (95,890)
Stock-based compensation expense 59,487       59,487    
Common stock issued upon settlement of stock-based compensation (in shares)       308      
Common stock issued upon settlement of stock-based compensation 10,243     $ 2 10,241    
Shares withheld related to net share settlement of stock-based compensation (in shares)       (104)      
Shares withheld related to net share settlement of stock-based compensation $ (34,695)       (34,695)    
Repurchase of common stock, including excise tax (in shares) (1,200)     (1,183)      
Repurchase of common stock, including excise tax $ (374,976)     $ (6) (2,096) (372,874)  
Ending balance (in shares) at Oct. 30, 2022   5,203 5,203        
Ending balance at Oct. 30, 2022 3,039,204   $ 0 $ 612 455,444 2,874,955 (291,807)
Ending balance (in shares) at Oct. 30, 2022       122,318      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares, issued (in shares)       122,334      
Beginning balance (in shares) at Jul. 31, 2022   5,203 5,203        
Beginning balance at Jul. 31, 2022 2,857,798   $ 0 $ 612 433,092 2,636,377 (212,283)
Beginning balance (in shares) at Jul. 31, 2022       122,334      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 255,470         255,470  
Other comprehensive income (loss), net of tax (79,524)           (79,524)
Stock-based compensation expense 20,312       20,312    
Common stock issued upon settlement of stock-based compensation (in shares)       45      
Common stock issued upon settlement of stock-based compensation 4,057       4,057    
Shares withheld related to net share settlement of stock-based compensation (in shares)       (6)      
Shares withheld related to net share settlement of stock-based compensation (1,917)       (1,917)    
Repurchase of common stock, including excise tax (in shares)       (55)      
Repurchase of common stock, including excise tax (16,992)       (100) (16,892)  
Ending balance (in shares) at Oct. 30, 2022   5,203 5,203        
Ending balance at Oct. 30, 2022 $ 3,039,204   $ 0 $ 612 455,444 2,874,955 (291,807)
Ending balance (in shares) at Oct. 30, 2022       122,318      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares, issued (in shares)       122,318      
Common stock, shares, issued (in shares) 122,205     122,205      
Beginning balance (in shares) at Jan. 29, 2023   5,116 5,116        
Beginning balance at Jan. 29, 2023 $ 3,148,799   $ 0 $ 611 474,645 2,926,127 (252,584)
Beginning balance (in shares) at Jan. 29, 2023 122,205     122,205      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 880,722         880,722  
Other comprehensive income (loss), net of tax (63,246)           (63,246)
Stock-based compensation expense 70,157       70,157    
Common stock issued upon settlement of stock-based compensation (in shares)       374      
Common stock issued upon settlement of stock-based compensation 24,937     $ 2 24,935    
Shares withheld related to net share settlement of stock-based compensation (in shares)       (95)      
Shares withheld related to net share settlement of stock-based compensation $ (30,877)       (30,877)    
Repurchase of common stock, including excise tax (in shares) (1,400)     (1,362)      
Repurchase of common stock, including excise tax $ (504,643)     $ (7) (2,470) (502,166)  
Ending balance (in shares) at Oct. 29, 2023   5,116 5,116        
Ending balance at Oct. 29, 2023 $ 3,525,849   $ 0 $ 606 536,390 3,304,683 (315,830)
Ending balance (in shares) at Oct. 29, 2023 121,122     121,122      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares, issued (in shares)       121,613      
Beginning balance (in shares) at Jul. 30, 2023   5,116 5,116        
Beginning balance at Jul. 30, 2023 $ 3,533,482   $ 0 $ 608 505,127 3,267,589 (239,842)
Beginning balance (in shares) at Jul. 30, 2023       121,613      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 248,714         248,714  
Other comprehensive income (loss), net of tax (75,988)           (75,988)
Stock-based compensation expense 24,573       24,573    
Common stock issued upon settlement of stock-based compensation (in shares)       67      
Common stock issued upon settlement of stock-based compensation 8,836     $ 2 8,834    
Shares withheld related to net share settlement of stock-based compensation (in shares)       (5)      
Shares withheld related to net share settlement of stock-based compensation (1,142)       (1,142)    
Repurchase of common stock, including excise tax (in shares)       (553)      
Repurchase of common stock, including excise tax (212,626)     $ (4) (1,002) (211,620)  
Ending balance (in shares) at Oct. 29, 2023   5,116 5,116        
Ending balance at Oct. 29, 2023 $ 3,525,849   $ 0 $ 606 $ 536,390 $ 3,304,683 $ (315,830)
Ending balance (in shares) at Oct. 29, 2023 121,122     121,122      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares, issued (in shares) 121,122     121,122